175 related articles for article (PubMed ID: 33505217)
1. The Relationship between Retinol-Binding Protein 4 and Markers of Inflammation and Thrombogenesis in Children with Kawasaki Disease.
Yang M; Weng H; Pei Q; Jing F; Yi Q
Mediators Inflamm; 2021; 2021():7029514. PubMed ID: 33505217
[TBL] [Abstract][Full Text] [Related]
2. Association between adropin and coronary artery lesions in children with Kawasaki disease.
Yang M; Pei Q; Zhang J; Weng H; Jing F; Yi Q
Eur J Pediatr; 2021 Jul; 180(7):2253-2259. PubMed ID: 33712900
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of circulating fibroblast growth factor 21 in children with Kawasaki disease.
Peng Y; Pei Q; Feng S; Su Y; Liu R; Yi Q; Guo P
Clin Exp Med; 2019 Nov; 19(4):457-462. PubMed ID: 31478099
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of C1q/tumor necrosis factor-related protein-1 in children with Kawasaki disease.
Feng S; Su Y; Luo L; Jing F; Yi Q
Pediatr Res; 2018 May; 83(5):999-1003. PubMed ID: 29360808
[TBL] [Abstract][Full Text] [Related]
5. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
Jing F; Weng H; Pei Q; Zhang J; Liu R; Yi Q
Clin Exp Med; 2022 Nov; 22(4):621-628. PubMed ID: 35039938
[TBL] [Abstract][Full Text] [Related]
6. Is There a Role for Laboratory Parameters in Predicting Coronary Artery Involvement in Kawasaki Disease?
Yalcinkaya R; Öz FN; Durmuş SY; Fettah A; Kaman A; Teke TA; Örün UA; Tanır G
Klin Padiatr; 2022 Nov; 234(6):382-387. PubMed ID: 35785802
[TBL] [Abstract][Full Text] [Related]
7. The role of Annexin A3 in coronary arterial lesions in children with Kawasaki disease.
Li M; Liu D; Jing F; Liu R; Yi Q
Front Pediatr; 2023; 11():1111788. PubMed ID: 36865686
[TBL] [Abstract][Full Text] [Related]
8. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
[TBL] [Abstract][Full Text] [Related]
9. Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease.
Liu R; Gao F; Huo J; Yi Q
Platelets; 2012; 23(1):11-6. PubMed ID: 21675937
[TBL] [Abstract][Full Text] [Related]
10. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease.
Duan Y; Li H; Luo D; Jiang J; Liu B; Li G
Int Immunopharmacol; 2023 Sep; 122():110600. PubMed ID: 37423157
[TBL] [Abstract][Full Text] [Related]
11. Prediction of coronary artery lesions based on C-reactive protein levels in children with Kawasaki Disease: a retrospective cohort study.
Shuai S; Zhang H; Zhang R; Tang M; Luo E; Yang Y; Gao Y; Yue S; Liang H; Cai J
J Pediatr (Rio J); 2023; 99(4):406-412. PubMed ID: 36977496
[TBL] [Abstract][Full Text] [Related]
12. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400
[TBL] [Abstract][Full Text] [Related]
13. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
Nandi A; Pal P; Basu S
Rheumatol Int; 2019 Oct; 39(10):1797-1801. PubMed ID: 31302740
[TBL] [Abstract][Full Text] [Related]
14. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3.
Chen YL; Wang JL; Li WQ
Eur J Pediatr; 2014 Nov; 173(11):1467-71. PubMed ID: 24889335
[TBL] [Abstract][Full Text] [Related]
16. Circulating endothelial glycocalyx components as a predictive marker of coronary artery lesions in Kawasaki disease.
Ohnishi Y; Yasudo H; Suzuki Y; Furuta T; Matsuguma C; Azuma Y; Miyake A; Okada S; Ichihara K; Ohga S; Hasegawa S
Int J Cardiol; 2019 Oct; 292():236-240. PubMed ID: 31200965
[TBL] [Abstract][Full Text] [Related]
17. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Jone PN; Anderson MS; Mulvahill MJ; Heizer H; Glodé MP; Dominguez SR
Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
[TBL] [Abstract][Full Text] [Related]
18. Increased concentrations of growth differentiation factor-15 in children with Kawasaki disease.
Li G; Wang T; Li J; Chen P; Jia P; Zhao J; Duan Y; Liu D; Xu X; Liu B
Clin Chim Acta; 2020 Aug; 507():264-270. PubMed ID: 32387635
[TBL] [Abstract][Full Text] [Related]
19. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
Shao S; Zhou K; Liu X; Liu L; Wu M; Deng Y; Duan H; Li Y; Hua Y; Wang C
J Clin Endocrinol Metab; 2021 Sep; 106(10):e4210-e4220. PubMed ID: 33837779
[TBL] [Abstract][Full Text] [Related]
20. Expression of nuclear factor -κBp65 in mononuclear cells in Kawasaki disease and its relation to coronary artery lesions.
Yin W; Wang X; Ding Y; Peng H; Liu YL; Wang RG; Yang YL; Xiong JH; Kang SX
Indian J Pediatr; 2011 Nov; 78(11):1378-82. PubMed ID: 21688043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]